ROPN1 遺伝子の発現は,積極的な乳がんにおける予知および予測バイオマーカー:臨床的影響と生存関連
Ricardo Cesar Cintra1, Andrés Galindo Céspedes2,3,4, Olinda Maria Gamarra5
1Center for Translational Research in Oncology, Instituto do Cancer do Estado de São Paulo ICESP, Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo FMUSP HC, São Paulo, Brazil.
European journal of breast health
|September 4, 2025
まとめ
ロポリン-1 (ROPN1) 遺伝子の過剰発現は,トリプルネガティブ乳がん (TNBC) の予後が悪いことを示しています. ROPN1は化学療法に対する耐性のバイオマーカーであり,新しい乳がん治療の標的となる可能性があります.
科学分野:
- 腫瘍学
- 遺伝学
- 分子生物学
背景:
- ロポリン-1 (ROPN1) 遺伝子は,最初は精子の運動性と関連しており,トリプルネガティブ乳がん (TNBC) で差異的な発現を示しています.
- これは,TNBCの進行と治療に対する耐性におけるROPN1の潜在的な役割を示唆する.
- ROPN1の機能を理解することは,攻撃的な乳がんの標的治療の開発に不可欠です.
研究 の 目的:
- 様々な乳がんサブタイプにおける ROPN1 遺伝子発現を包括的に特徴づける.
- ROPN1濃度と臨床病理学的特徴,患者の生存率,化学療法への反応との関連を調査する.
- TNBCの潜在的翻訳バイオマーカーとしてROPN1を評価する.
主な方法:
- 大規模な患者コホートにおけるROPN1の転写値の分析 (がんゲノムアトラス,スウェーデンがんゲノム分析ネットワーク-乳房).
- ROPN1発現と臨床的変数と生存結果の相関
- 化学療法剤と表遺伝子変調剤によるROPN1の調節を評価するために,乳がん細胞系を用いたインビトロ研究.
主要な成果:
- ROPN1の過剰発現はTNBC/基礎型の腫瘍において有意に濃縮され,全生存率の低下と関連しています.
- 特に化学療法を受けた患者では,高レベルのROPN1は予後不良を予測する.
- エピジェネティックの変化,特にCpGの特定の部位における低メチル化は,経路の調節不良を示唆する生存率の低下と相関しています.
結論:
- ROPN1の過剰発現はTNBCの予後バイオマーカーとして機能し,化学療法後の悪い結果と耐性を予測します.
- ROPN1と関連する転移前経路を標的とした治療は,新しい治療戦略を提供することができる.
- 乳がんにおけるROPN1のさらなる調査は,攻撃的な乳がんの精密医療アプローチを強化する可能性があります.
さらに関連する動画
関連する概念動画
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Cancer-Critical Genes I: Proto-oncogenes
9.1K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.1K
The Retinoblastoma Gene
4.2K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
lncRNA - Long Non-coding RNAs
8.9K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.9K


